These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7865547)

  • 1. Estimate of relative function and transit time in renographic studies.
    González A; Ros D; Pavia J
    J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum sample times for single-injection, multisample renal clearance methods.
    Russell CD
    J Nucl Med; 1993 Oct; 34(10):1761-5. PubMed ID: 8410295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
    Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
    J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single-injection multisample renal clearance methods with and without urine collection.
    Russell CD; Dubovsky EV
    J Nucl Med; 1995 Apr; 36(4):603-6. PubMed ID: 7699449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
    Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A
    Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of renal function using MAG3.
    Russell CD; Dubovsky EV
    J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats.
    Pathuri G; Sahoo K; Awasthi V; Gali H
    Nucl Med Commun; 2011 Oct; 32(10):908-12. PubMed ID: 21876402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
    Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
    Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
    Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
    Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
    Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
    Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of renal function with technetium-99m MAG3.
    Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
    J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of renal transplant survival from early postoperative radioisotope studies.
    Russell CD; Yang H; Gaston RS; Hudson SL; Diethelm AG; Dubovsky EV
    J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
    Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
    J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA].
    Torizuka K; Ishibashi A; Ikekubo K; Yamamoto K; Nishibuchi S
    Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F; Laznicek M; Laznickova A
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.